Resources

Clinical

Data Insights: Identifying Early Signs of Safety and Efficacy in Oncology Clinical Trials

August 28, 2020
Read Now
 
TD2 Blog TD2 Blog

White Papers

Clinical

Technology and Next-Generation Oncology Trials

While cancer drug trials have seen many changes recently, one thing is certain – technology innovations are emerging as key components of any trial. CROs leverage different technological tools that improve patient recruitment, digital engagement, compliance, integration of disparate data sources, and data analytics.

Read Download White Paper
Clinical

The Trends Behind Successful Cancer Treatments

The approval and success of powerful new cancer treatments such as CAR T-cell therapy are breeding optimism among companies, scientists and patients around the world.TD2 can help influence your trial design and get your drug on a faster path to approval.

Read Download White Paper
Bioanalytical

The A-Z Guide of DMPK Assays and How to Find the Right One

You might know you need to conduct drug metabolism and pharmacokinetic (DMPK) analysis, but which tests are right for your project? And are you doing them at the right time? When building your preclinical strategy, these questions matter—and that’s true now more than ever, as new drug classes and targets emerge.

Read Download White Paper
Preclinical

6 Signs You Need a New CRO for Your Preclinical Research

You have goals for every project, and your CRO should be as committed to those goals as you are. But if things take too long to get done,it might be time to switch CROs instead. Learn to spot these six signs your preclinical work needs a new CRO.

Read Download White Paper
Clinical

The Quick-Start Guide to Clinical Strategy

Drug research has advanced in remarkable ways, but it’s still about the basics: ensuring safety, efficacy and compliance. That trio is no easy feat, but without a strong clinical strategy, even the most promising, safe and compliant drug can fail. Get your research in better strategic shape with this quick-start plan.

Read Download White Paper
Preclinical

CAR T-Cell Therapy: Revolutionizing Cancer Treatment

Ready your research for success with expert insight from TD2 on how to launch a successful CAR-T trial. Learn the key areas to take into account when beginning this type of oncology trial to ensure proper trial preclinical study design, uncover efficiencies and identify toxicity.

Read Download White Paper

Industry News

Recent Blog Posts
Get free tips, tools and resources by subscribing to the TD2 Newsletter: